Status: current, Defined. Date: 31-Jul 2014. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3026721000168115 | Xolair (omalizumab 150 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3026731000168117 | Xolair 150 mg/mL injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Xolair 150 mg/mL injection, syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
Xolair 150 mg/mL injection, syringe | has unit of use | syringe | true | Inferred relationship | Some | 1183718783 | |
Xolair 150 mg/mL injection, syringe | has intended active ingredient | omalizumab | true | Inferred relationship | Some | 1183718782 | |
Xolair 150 mg/mL injection, syringe | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Xolair 150 mg/mL injection, syringe | Is a | Xolair | true | Inferred relationship | Some | ||
Xolair 150 mg/mL injection, syringe | Is a | omalizumab 150 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use) | true | Inferred relationship | Some | ||
Xolair 150 mg/mL injection, syringe | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
Xolair 150 mg/mL injection, syringe | has Australian BoSS | omalizumab | true | Inferred relationship | Some | 1183718782 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Xolair 150 mg/mL injection, 1 mL syringe | has TPUU | True | Xolair 150 mg/mL injection, syringe | Inferred relationship | Some | 1 |
Xolair 150 mg/mL injection, 1 mL syringe | has TPUU | True | Xolair 150 mg/mL injection, syringe | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set